The potential of MAO inhibitors as chemotherapeutics in cancer: a literature survey
S Sblano, A Boccarelli, C Deruvo, G La Spada… - European Journal of …, 2024 - Elsevier
Drug resistance in cancer is determined by genetic mutations and adaptations of tumor cells
to drug treatments, raising a challenge in the treatment of cancer. Factors such as prolonged …
to drug treatments, raising a challenge in the treatment of cancer. Factors such as prolonged …
Anticancer Effect of Mycotoxins From Penicillium aurantiogriseum: Exploration of Natural Product Potential
A Bouhoudan, J Bakkach, M Khaddor… - International Journal …, 2024 - Wiley Online Library
Research into biologically natural substances with antitumor properties, known for their
potential to induce fewer side effects and exhibit specificity toward cancerous cells, remains …
potential to induce fewer side effects and exhibit specificity toward cancerous cells, remains …
[HTML][HTML] Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)
I Alsaad, DMA Abdel Rahman, O Al-Tamimi, SA Alhaj… - Molecules, 2024 - mdpi.com
Monoamine oxidase B (MAO-B) is a key enzyme in the mitochondrial outer membrane,
pivotal for the oxidative deamination of biogenic amines. Its overexpression has been …
pivotal for the oxidative deamination of biogenic amines. Its overexpression has been …
[PDF][PDF] ВЛИЯНИЕ НЕКОТОРЫХ ГЕТЕРОЦИКЛИЧЕСКИХ, ЦИКЛИЧЕСКИХ И АЗОТСОДЕРЖАЩИХ СОЕДИНЕНИЙ НА ПРОЛИФЕРАЦИЮ КЛЕТОК ОТДЕЛЬНЫХ …
МЛ Благонравов, СП Сяткин - rudn.ru
Полиамины (ПА)(спермидин (Спд), спермин (Спм), путресцин) осуществляют регуляцию
процессов клеточного роста, пролиферации и дифференцировки [Gamble LD et al …
процессов клеточного роста, пролиферации и дифференцировки [Gamble LD et al …